Immunoinformatics Prediction and Protective Efficacy of Vaccine Candidate PiuA-PlyD4 Against Streptococcus Pneumoniae

References

• O’Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893–902. doi:10.1016/S0140-6736(09)61204-6
   PubMed Web of Science ®Google Scholar
• Williams AE, Jose RJ, Brown JS, Chambers RC. Enhanced inflammation in aged mice following infection with Streptococcus pneumoniae is associated with decreased IL-10 and augmented chemokine production. Am J Physiol Lung Cell Mol Physiol. 2015;308(6):L539–49. doi:10.1152/ajplung.00141.2014
   PubMed Web of Science ®Google Scholar
• van de Garde MDB, Knol MJ, Rots NY, van Baarle D, van Els C. Vaccines to protect older adults against pneumococcal disease. Interdiscip Top Gerontol Geriatr. 2020;43:113–130. doi:10.1159/000504490
   PubMedGoogle Scholar
• Berical AC, Harris D, Dela Cruz CS, Possick JD. Pneumococcal vaccination strategies. An update and perspective. Ann Am Thorac Soc. 2016;13(6):933–944. doi:10.1513/AnnalsATS.201511-778FR
   PubMed Web of Science ®Google Scholar
• Lagousi T, Basdeki P, De Jonge MI, Spoulou V. Understanding host immune responses to pneumococcal proteins in the upper respiratory tract to develop serotype-independent pneumococcal vaccines. Expert Rev Vaccines. 2020;19(10):959–972. doi:10.1080/14760584.2020.1843433
   PubMed Web of Science ®Google Scholar
• Colombo MJ, Sun G, Alugupalli KR. T-cell-independent immune responses do not require CXC ligand 13-mediated B1 cell migration. Infect Immun. 2010;78(9):3950–3956. doi:10.1128/IAI.00371-10
   PubMed Web of Science ®Google Scholar
• Prinz DM, Smithson SL, Westerink MA. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C. J Immunol Methods. 2004;285(1):1–14. doi:10.1016/j.jim.2003.08.005
   PubMed Web of Science ®Google Scholar
• Geno KA, Gilbert GL, Song JY, et al. Pneumococcal capsules and their types: past, present, and future. Clin Microbiol Rev. 2015;28(3):871–899. doi:10.1128/Cmr.00024-15
   PubMed Web of Science ®Google Scholar
• Josefsberg JO, Buckland B. Vaccine process technology. Biotechnol Bioeng. 2012;109(6):1443–1460. doi:10.1002/bit.24493
   PubMed Web of Science ®Google Scholar
• Tai SS. Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit Rev Microbiol. 2006;32(3):139–153. doi:10.1080/10408410600822942
   PubMed Web of Science ®Google Scholar
• Alghofaili F, Najmuldeen H, Kareem BO, et al. Host stress signals stimulate pneumococcal transition from colonization to dissemination into the lungs. mBio. 2021;12(6):e0256921. doi:10.1128/mBio.02569-21
   PubMed Web of Science ®Google Scholar
• Jomaa M, Yuste J, Paton JC, Jones C, Dougan G, Brown JS. Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae. Infect Immun. 2005;73(10):6852–6859. doi:10.1128/IAI.73.10.6852-6859.2005
   PubMed Web of Science ®Google Scholar
• Chiu FF, Leng CH, Ding YJ, et al. Domain 4 of pneumolysin from Streptococcus pneumoniae is a multifunctional domain contributing TLR4 activating and hemolytic activity. Biochem Biophys Res Commun. 2019;517(4):596–602. doi:10.1016/j.bbrc.2019.07.063
   PubMed Web of Science ®Google Scholar
• Cui Y, Miao C, Chen W, et al. Construction and protective efficacy of a novel Streptococcus pneumoniae fusion protein vaccine NanAT1-TufT1-PlyD4. Front Immunol. 2022;13:1043293. doi:10.3389/fimmu.2022.1043293
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang H, Zhang S, et al. Mucosal immunization with recombinant fusion protein DnaJ-DeltaA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A. Infect Immun. 2014;82(4):1666–1675. doi:10.1128/IAI.01391-13
   PubMed Web of Science ®Google Scholar
• Guo X, Sun Q, Xi H, et al. Expression, purification, and characterization of pneumococcal PsaA-PspA fusion protein. Protein Expr Purif. 2021;178:105782. doi:10.1016/j.pep.2020.105782
   PubMed Web of Science ®Google Scholar
• Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003;31(13):3784–3788. doi:10.1093/nar/gkg563
   PubMed Web of Science ®Google Scholar
• Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinf. 2007;8:4. doi:10.1186/1471-2105-8-4
   PubMed Web of Science ®Google Scholar
• Dimitrov I, Flower DR, Doytchinova I. AllerTOP--a server for in silico prediction of allergens. BMC Bioinf. 2013;14(Suppl 6):S4. doi:10.1186/1471-2105-14-S6-S4
   PubMed Web of Science ®Google Scholar
• Sobolev OV, Afonine PV, Moriarty NW, et al. A global Ramachandran score identifies protein structures with unlikely stereochemistry. Structure. 2020;28(11):1249–1258. doi:10.1016/j.str.2020.08.005
   PubMed Web of Science ®Google Scholar
• Ponomarenko J, Bui HH, Li W, et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinf. 2008;9:514. doi:10.1186/1471-2105-9-514
   PubMed Web of Science ®Google Scholar
• Reynisson B, Alvarez B, Paul S, Peters B, Nielsen M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 2020;48(W1):W449–W454. doi:10.1093/nar/gkaa379
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Huda S, Sinha Babu SP. Toll-like receptor polymorphism in host immune response to infectious diseases: a review. Scand J Immunol. 2019;90(1):e12771. doi:10.1111/sji.12771
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Karmakar S, Babu SP. TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review. Braz J Infect Dis. 2016;20(2):193–204. doi:10.1016/j.bjid.2015.10.011
   PubMed Web of Science ®Google Scholar
• Yan Y, Tao H, He J, Huang SY. The HDOCK server for integrated protein-protein docking. Nat Protoc. 2020;15(5):1829–1852. doi:10.1038/s41596-020-0312-x
   PubMed Web of Science ®Google Scholar
• Kumari R, Kumar R. Open source drug discovery consortium, Lynn A. g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model. 2014;54(7):1951–1962. doi:10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Mahmud S, Rafi MO, Paul GK, et al. Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach. Sci Rep. 2021;11(1):15431. doi:10.1038/s41598-021-92176-1
   PubMed Web of Science ®Google Scholar
• Shafaghi M, Bahadori Z, Madanchi H, Ranjbar MM, Shabani AA, Mousavi SF. Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains. BMC Bioinf. 2023;24(1):67. doi:10.1186/s12859-023-05175-6
   PubMed Web of Science ®Google Scholar
• Gurung AB, Bhattacharjee A. Impact of a non-synonymous Q281R polymorphism on structure of human Lipoprotein-Associated Phospholipase A(2) (Lp-PLA(2)). J Cell Biochem. 2018;119(8):7009–7021. doi:10.1002/jcb.26909
   PubMed Web of Science ®Google Scholar
• Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007;35:W407–10. doi:10.1093/nar/gkm290
   PubMed Web of Science ®Google Scholar
• Messaoudi A, Belguith H, Ben Hamida J. Homology modeling and virtual screening approaches to identify potent inhibitors of VEB-1 beta-lactamase. Theor Biol Med Model. 2013;10:22. doi:10.1186/1742-4682-10-22
   PubMed Web of Science ®Google Scholar
• Yang Z, Bogdan P, Nazarian S. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study. Sci Rep. 2021;11(1):3238. doi:10.1038/s41598-021-81749-9
   PubMed Web of Science ®Google Scholar
• Yilmaz Colak C. Computational design of a multi-epitope vaccine against clostridium chauvoei: an immunoinformatics approach. Int J Pept Res Ther. 2021;27(4):2639–2649. doi:10.1007/s10989-021-10279-9
   PubMed Web of Science ®Google Scholar
• He Y, Li J, Mao W, et al. HLA common and well-documented alleles in China. HLA. 2018;92(4):199–205. doi:10.1111/tan.13358
   PubMed Web of Science ®Google Scholar
• Yan Y, Wen Z, Wang X, Huang SY. Addressing recent docking challenges: a hybrid strategy to integrate template-based and free protein-protein docking. Proteins. 2017;85(3):497–512. doi:10.1002/prot.25234
   PubMed Web of Science ®Google Scholar
• Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol. 2018;16(6):355–367. doi:10.1038/s41579-018-0001-8
   PubMed Web of Science ®Google Scholar
• Whalan RH, Funnell SG, Bowler LD, Hudson MJ, Robinson A, Dowson CG. PiuA and PiaA, iron uptake lipoproteins of Streptococcus pneumoniae, elicit serotype independent antibody responses following human pneumococcal septicaemia. FEMS Immunol Med Microbiol. 2005;43(1):73–80. doi:10.1016/j.femsim.2004.07.010
   PubMedGoogle Scholar
• Zhang Y, Edmonds KA, Raines DJ, et al. The pneumococcal iron uptake protein a (PiuA) specifically recognizes Tetradentate Fe(III)bis- and mono-catechol complexes. J Mol Biol. 2020;432(19):5390–5410. doi:10.1016/j.jmb.2020.08.005
   PubMed Web of Science ®Google Scholar
• Dorosti H, Eslami M, Negahdaripour M, et al. Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine. J Biomol Struct Dyn. 2019;37(13):3524–3535. doi:10.1080/07391102.2018.1519460
   PubMed Web of Science ®Google Scholar
• Matthias KA, Roche AM, Standish AJ, Shchepetov M, Weiser JN. Neutrophil-toxin interactions promote antigen delivery and mucosal clearance of Streptococcus pneumoniae. J Immunol. 2008;180(9):6246–6254. doi:10.4049/jimmunol.180.9.6246
   PubMed Web of Science ®Google Scholar
• Chen X, Zaro JL, Shen WC. Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev. 2013;65(10):1357–1369. doi:10.1016/j.addr.2012.09.039
   PubMed Web of Science ®Google Scholar
• van de Garde MDB, van Westen E, Poelen MCM, Rots NY, van Els C. Prediction and validation of immunogenic domains of pneumococcal proteins recognized by human CD4(+) T cells. Infect Immun. 2019;87(6):e00098–19. doi:10.1128/IAI.00098-19
   PubMed Web of Science ®Google Scholar
• Das NC, Sen Gupta PS, Biswal S, Patra R, Rana MK, Mukherjee S. In-silico evidences on filarial cystatin as a putative ligand of human TLR4. J Biomol Struct Dyn. 2022;40(19):8808–8824. doi:10.1080/07391102.2021.1918252
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Mukherjee S, Maiti TK, Bhattacharya S, Sinha Babu SP. A novel ligand of toll-like receptor 4 from the sheath of Wuchereria bancrofti microfilaria induces proinflammatory response in macrophages. J Infect Dis. 2017;215(6):954–965. doi:10.1093/infdis/jix067
   PubMed Web of Science ®Google Scholar
• Choudhury A, Sen Gupta PS, Panda SK, Rana MK, Mukherjee S. Designing AbhiSCoVac - a single potential vaccine for all ‘Corona culprits’: immunoinformatics and immune simulation approaches. J Mol Liq. 2022;351:118633. doi:10.1016/j.molliq.2022.118633
   PubMed Web of Science ®Google Scholar
• Das NC, Gupta PSS, Panda SK, Rana MK, Mukherjee S. Reverse vaccinology assisted design of a novel multi-epitope vaccine to target Wuchereria bancrofti cystatin: an immunoinformatics approach. Int Immunopharmacol. 2023;115:109639. doi:10.1016/j.intimp.2022.109639
   PubMed Web of Science ®Google Scholar
• Usmani SS, Kumar R, Bhalla S, Kumar V, Raghava GPS. In silico tools and databases for designing peptide-based vaccine and drugs. Adv Protein Chem Struct Biol. 2018;112:221–263. doi:10.1016/bs.apcsb.2018.01.006
   PubMed Web of Science ®Google Scholar
• Yu J, Li B, Chen X, et al. Comparison of immunogenicity and protection of two pneumococcal protein vaccines based on PsaA and PspA. Infect Immun. 2018;86(6):e00916–17. doi:10.1128/IAI.00916-17
   PubMed Web of Science ®Google Scholar
• Gil E, Noursadeghi M, Brown JS. Streptococcus pneumoniae interactions with the complement system. Front Cell Infect Microbiol. 2022;12:929483. doi:10.3389/fcimb.2022.929483
   PubMed Web of Science ®Google Scholar
• Chen X, Li B, Yu J, et al. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant. Med Microbiol Immunol. 2019;208(2):215–226. doi:10.1007/s00430-019-00579-9
   PubMed Web of Science ®Google Scholar
• Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4(3):144–154. doi:10.1016/S1473-3099(04)00938-7
   PubMed Web of Science ®Google Scholar
• Casadevall A. Antibody-based vaccine strategies against intracellular pathogens. Curr Opin Immunol. 2018;53:74–80. doi:10.1016/j.coi.2018.04.011
   PubMed Web of Science ®Google Scholar
• Platt HL, Cardona JF, Haranaka M, et al. A Phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE). Vaccine. 2022;40(1):162–172. doi:10.1016/j.vaccine.2021.08.049
   PubMed Web of Science ®Google Scholar